Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice
- PMID: 19622825
- PMCID: PMC2792581
- DOI: 10.1001/jama.2009.1073
Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice
Comment on
-
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064. JAMA. 2009. PMID: 19622817
Similar articles
-
Biomarkers for Alzheimer's disease. The research advances incrementally, but clinical use is still years away.Harv Ment Health Lett. 2010 Nov;27(5):1-3. Harv Ment Health Lett. 2010. PMID: 21218612 No abstract available.
-
A cerebrospinal fluid biosignature for the diagnosis of Alzheimer's disease.Braz J Psychiatry. 2019 Nov-Dec;41(6):467-468. doi: 10.1590/1516-4446-2019-0629. Braz J Psychiatry. 2019. PMID: 31826090 Free PMC article. No abstract available.
-
Use of cerebrospinal fluid biomarkers for diagnosis of incipient Alzheimer disease in patients with mild cognitive impairment.Clin Chem. 2010 Jan;56(1):7-9. doi: 10.1373/clinchem.2009.134692. Epub 2009 Nov 19. Clin Chem. 2010. PMID: 19926774 No abstract available.
-
The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.Med Clin North Am. 2013 May;97(3):369-76. doi: 10.1016/j.mcna.2012.12.012. Epub 2013 Feb 1. Med Clin North Am. 2013. PMID: 23642576 Review.
-
Biochemical markers in Alzheimer's disease clinical trials.Biomark Med. 2010 Feb;4(1):91-8. doi: 10.2217/bmm.09.80. Biomark Med. 2010. PMID: 20387305 Review.
Cited by
-
Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria.Front Aging Neurosci. 2014 Mar 24;6:47. doi: 10.3389/fnagi.2014.00047. eCollection 2014. Front Aging Neurosci. 2014. PMID: 24715863 Free PMC article. Review.
-
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.Alzheimers Dement. 2010 May;6(3):230-8. doi: 10.1016/j.jalz.2010.03.008. Alzheimers Dement. 2010. PMID: 20451871 Free PMC article. Review.
-
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001. Alzheimers Dement. 2015. PMID: 26073027 Free PMC article. Review.
-
Biomarkers of Alzheimer's disease: from central nervous system to periphery?Int J Alzheimers Dis. 2010 Dec 20;2011:342980. doi: 10.4061/2011/342980. Int J Alzheimers Dis. 2010. PMID: 21197431 Free PMC article.
-
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Epub 2013 Aug 7. Alzheimers Dement. 2013. PMID: 23932184 Free PMC article. Review.
References
-
- Mattsson N, Zetterberg H, Hansson O, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302(4):385–393. - PubMed
-
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308. - PubMed
-
- Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Archives of Neurology. 2001;58:1985–1992. - PubMed
-
- Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine. 2004;256:183–194. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical